News - Jazz Pharmaceuticals, Neurological

Filter

Popular Filters

Jazz Pharma and Concert ink deal on deuterium-modified sodium oxybate

27-02-2013

US drugmakers Jazz Pharmaceuticals (Nasdaq: JAZZ) and Concert Pharmaceuticals have entered into an exclusive…

BiotechnologyConcert PharmaceuticalsJazz PharmaceuticalsLicensingNeurologicalPharmaceuticalResearchsodium oxybateZyrem

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top